145 related articles for article (PubMed ID: 8535196)
1. MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy.
Finnegan MC; Royds J; Goepel JR; Lorigan P; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Jul; 18(3-4):297-302. PubMed ID: 8535196
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas.
Finnegan MC; Goepel JR; Royds J; Hancock BW; Goyns MH
Cancer Lett; 1994 Nov; 86(2):215-21. PubMed ID: 7982210
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers.
Schlaifer D; Laurent G; Chittal S; Tsuruo T; Soues S; Muller C; Charcosset JY; Alard C; Brousset P; Mazerrolles C
Br J Cancer; 1990 Aug; 62(2):177-82. PubMed ID: 1974813
[TBL] [Abstract][Full Text] [Related]
4. Activation of MYCN in a case of non-Hodgkin's lymphoma.
Finnegan MC; Hammond DW; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Aug; 18(5-6):511-4. PubMed ID: 8528061
[TBL] [Abstract][Full Text] [Related]
5. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
6. Modulation of multidrug resistance (MDR) in hematological malignancies.
Covelli A
Ann Oncol; 1999; 10 Suppl 6():53-9. PubMed ID: 10676553
[TBL] [Abstract][Full Text] [Related]
7. Changed expression and function of P-gp in peripheral blood CD56 + cells predicting chemoresistance in non-Hodgkin lymphoma patients.
Han L; Guo X; Bian H; Zhou Y; Li T; Yang J
Cancer Biomark; 2015; 15(3):289-97. PubMed ID: 25769453
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation.
Foroutan B; Zitzelsberger H; Bauer V; Ruf AA; Baumgartner A; Anderson D
Arch Iran Med; 2011 Sep; 14(5):321-6. PubMed ID: 21888455
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of P-glycoprotein expression in haematological malignancies.
Nooter K; Sonneveld P
Leuk Res; 1994 Apr; 18(4):233-43. PubMed ID: 7909572
[TBL] [Abstract][Full Text] [Related]
10. Expression of P-glycoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma.
Rodriguez C; Commes T; Robert J; Rossi JF
Leuk Res; 1993 Feb; 17(2):149-56. PubMed ID: 8094105
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.
Jimenez RE; Zalupski MM; Frank JJ; Du W; Ryan JR; Lucas DR
Cancer; 1999 Sep; 86(6):976-81. PubMed ID: 10491523
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas.
Weide R; Tiemann M; Pflüger KH; Köppler H; Parvizl B; Wacker HH; Kreipe HH; Havemann K; Parwaresch MR
Leukemia; 1994 Jan; 8(1):97-101. PubMed ID: 8289506
[TBL] [Abstract][Full Text] [Related]
13. Expression of MDR-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells.
Ota S; Sato T; Kakuda H; Hirano K; Okimoto Y; Mori T; Nakazawa S; Kojima S; Matsuyama T; Tsuruo T
Leuk Lymphoma; 1995 Nov; 19(5-6):431-6. PubMed ID: 8590843
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance-associated protein (MRP) in haematological malignancies.
Nooter K; Burger H; Stoter G
Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
[TBL] [Abstract][Full Text] [Related]
15. c-myc mRNA expression in non-Hodgkin's lymphomas.
Fellbaum C; Radaszkiewicz T; Ruhri C; Pütz B; Lehmacher W; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):61-8. PubMed ID: 1352077
[TBL] [Abstract][Full Text] [Related]
16. Alternative (non-P-glycoprotein) mechanisms of drug resistance in non-Hodgkin's lymphoma.
Dalton WS
Hematol Oncol Clin North Am; 1997 Oct; 11(5):975-86. PubMed ID: 9336726
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the p53 gene, its expression and protein stabilization in non-Hodgkin's lymphomas.
Lee KA; Finnegan MC; Sheridan E; Hancock BW; Goepel JR; Royds J; Goyns MH
Ann Oncol; 1994; 5 Suppl 1():85-8. PubMed ID: 8172825
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance (MDR) genes in haematological malignancies.
Nooter K; Sonneveld P
Cytotechnology; 1993; 12(1-3):213-30. PubMed ID: 7765326
[TBL] [Abstract][Full Text] [Related]
19. The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance.
Moore AS; Leveille CR; Reimann KA; Shu H; Arias IM
Cancer Invest; 1995; 13(5):475-9. PubMed ID: 7552813
[TBL] [Abstract][Full Text] [Related]
20. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
